Avery Dennison Announces Fourth Quarter and Full Year 2020 Results
Highlights:
-
4Q20 Reported EPS of
$2.28 , up 19%-
Adjusted EPS (non-GAAP) of
$2.27 , up 31%
-
Adjusted EPS (non-GAAP) of
-
4Q20 Net sales increased 12.3% to
$1.99 billion - Sales change ex. currency (non-GAAP) of 5.2%
- Organic sales change (non-GAAP) of 3.2%
-
FY20 Reported EPS of
$6.61 , up 85%-
Adjusted EPS of
$7.10 , up 8%
-
Adjusted EPS of
-
FY20 Net sales declined 1.4% to
$6.97 billion - Sales change ex. currency of (1.7%)
- Organic sales change of (3.4%)
-
Free Cash Flow of
$548 million in 2020
“We delivered another year of strong earnings growth in 2020,” said
“We were able to protect, even expand, margins, despite pandemic-related market declines particularly in the second quarter,” added Butier. “Underlying label demand in LGM, our largest business, remained strong throughout the downturn, while volume trends improved sequentially in RBIS and IHM in the second half. RFID grew significantly due to continued strong organic growth and the acquisition of Smartrac.
“As we enter 2021, we remain confident in our ability to continue to make progress toward our long-term goals, including consistent delivery of GDP+ growth and top-quartile return on capital,” added Butier.
“We continue to prove our resilience across business cycles,” said Butier. “I want to thank our entire team for their ongoing efforts to keep one another safe while continuing to deliver for all our stakeholders during this challenging period.”
COVID-19 Update
The safety and well-being of employees has been and will continue to be the company’s top priority during this global health crisis. The company has taken steps to both ensure employee safety, as well as help mitigate the financial impact to employees resulting from mandated facility closures and necessary layoffs in early 2020. In addition, the company recently provided one-time payments to frontline workers to express gratitude for their effort and dedication throughout this difficult time.
Additionally, the company has increased community engagement during the crisis, including electing to make a
Throughout the pandemic, the company has continued to work closely with customers to continue to deliver industry-leading products and services. Operationally, all manufacturing sites remained open during the second half of the year. Throughout the health crisis, disruptions to the company’s supply chain have been negligible.
Balance Sheet, Liquidity, and Capital Deployment
The company’s balance sheet remains strong, with ample liquidity. Net debt to adjusted EBITDA (non-GAAP) was 1.7 as of the end of the fourth quarter, below our long-term target of 2.3 to 2.6.
The company’s long-term priorities for capital allocation support its primary objectives of delivering faster growth in high value categories alongside profitable growth of its base businesses. These priorities are unchanged in the current environment.
The company continues to protect its investments in high value categories, particularly RFID, and increased its pace of capital spending in the fourth quarter compared to previous expectations. Total capital spending for the year was
The company closed two strategic acquisitions during the year, ACPO in the fourth quarter for
Additionally, for the fourth quarter and full year 2020, the company repurchased 0.4 and 0.8 million shares, respectively, at an aggregate cost of
Fourth Quarter 2020 Results
Net sales were
Reported operating margin increased 350 basis points to 13.7%. Adjusted EBITDA margin increased 180 basis points to 16.3%, while adjusted operating margin increased 160 basis points to 13.5%.
Reported net income was
Year-to-date free cash flow was
Fourth Quarter 2020 Results by Segment
Label and Graphic Materials
-
Reported sales increased 10.1%. Sales were up 3.6% on an organic basis.
- Label and Packaging Materials sales were up a mid-single digit from prior year on an organic basis.
- Sales declined by a mid-single digit organically in the combined Graphics and Reflective Solutions businesses.
-
On an organic basis, sales were up a mid-single digit in
North America and emerging markets, and roughly flat inWestern Europe .
- Reported operating margin increased 390 basis points to 15.9%, as the benefits of productivity, favorable volume/mix, lower restructuring charges, as well as raw material deflation, net of pricing more than offset higher employee-related costs. Adjusted operating margin increased 210 basis points to 15.4%.
Retail Branding and Information Solutions
-
Reported sales increased 19.0%. Sales were up 11.6% ex. currency, and up 3.1% on an organic basis, as strong organic growth in high value categories was partially offset by a low-to-mid-single digit decline in the base business, driven by overall lower apparel demand. Sales ex. currency growth also reflected contribution from the Smartrac acquisition.
- Enterprise-wide sales of RFID products were up approximately 55% ex. currency with the benefit of the Smartrac acquisition, and up approximately 21% organically, driven by new programs and recovery in the value segment of the apparel market.
- Reported operating margin increased 380 basis points to 15.3%, as the benefits of productivity, favorable volume, and lower restructuring charges more than offset higher employee-related costs. Adjusted operating margin increased 210 basis points to 15.7%.
Industrial and Healthcare Materials
- Reported sales increased 10.8%. On an organic basis, sales increased 0.7%, reflecting a high-single digit increase in industrial categories, and a mid-single digit decline in healthcare categories.
- Reported operating margin increased 520 basis points to 12.4%, as the benefits of lower restructuring charges, favorable volume/mix, and productivity more than offset the impact of higher employee-related costs. Adjusted operating margin increased 210 basis points to 12.3%.
Other
Income Taxes
The company’s reported effective tax rate was 24.6% for the fourth quarter and 24.1% for the full year. The company’s adjusted (non-GAAP) tax rate was 24.1% for the fourth quarter and full year.
The company’s 2021 adjusted tax rate is expected to be in the mid-twenty percent range, based on current tax regulations.
Cost Reduction Actions
In the fourth quarter and full year 2020, the company realized approximately
Outlook
In its supplemental presentation materials, “Fourth Quarter and Full Year 2020 Financial Review and Analysis,” the company provides a list of factors that it believes will contribute to its 2021 financial results. Based on the factors listed and other assumptions, the company expects 2021 reported earnings per share of
Excluding an estimated
For more details on the company’s results, see the summary tables accompanying this news release, as well as the supplemental presentation materials, “Fourth Quarter and Full Year 2020 Financial Review and Analysis,” posted on the company’s website at www.investors.averydennison.com, and furnished to the
Throughout this release and the supplemental presentation materials, amounts on a per share basis reflect fully diluted shares outstanding.
About Avery Dennison
Avery Dennison (NYSE: AVY) is a global materials science company specializing in the design and manufacture of a wide variety of labeling and functional materials. The company’s products, which are used in nearly every major industry, include pressure-sensitive materials for labels and graphic applications; tapes and other bonding solutions for industrial, medical, and retail applications; tags, labels and embellishments for apparel; and radio frequency identification (RFID) solutions serving retail apparel and other markets. Headquartered in
# # #
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995
Certain statements contained in this document are "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements, and financial or other business targets, are subject to certain risks and uncertainties. We believe that the most significant risk factors that could affect our financial performance in the near-term include: (i) the impacts to our business from global economic conditions, political uncertainty, changes in environmental standards and governmental regulations, including as a result of the coronavirus/COVID-19 pandemic; (ii) competitors' actions, including pricing, expansion in key markets, and product offerings; (iii) the degree to which higher costs can be offset with productivity measures and/or passed on to customers through price increases, without a significant loss of volume; and (iv) the execution and integration of acquisitions.
Actual results and trends may differ materially from historical or anticipated results depending on a variety of factors, including but are not limited to, risks and uncertainties relating to the following: the coronavirus/COVID-19 pandemic; fluctuations in demand affecting sales to customers; worldwide and local economic and market conditions; changes in political conditions; fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets; changes in our markets due to competitive conditions, technological developments, laws and regulations, and customer preferences; fluctuations in the cost and availability of raw materials and energy; changes in governmental laws and regulations; the impact of competitive products and pricing; the financial condition and inventory strategies of customers; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; loss of significant contracts or customers; collection of receivables from customers; selling prices; business mix shift; execution and integration of acquisitions; product and service quality; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; amounts of future dividends and share repurchases; customer and supplier concentrations or consolidations; fluctuations in interest and tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; retention of tax incentives; outcome of tax audits; successful implementation of new manufacturing technologies and installation of manufacturing equipment; disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; data security breaches; volatility of financial markets; impairment of capitalized assets, including goodwill and other intangibles; credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; the realization of deferred tax assets; fluctuations in interest rates; compliance with our debt covenants; fluctuations in pension, insurance, and employee benefit costs; goodwill impairment; the impact of legal and regulatory proceedings, including with respect to environmental, health and safety, anti-corruption and trade compliance; protection and infringement of intellectual property; the impact of epidemiological events on the economy and our customers and suppliers; acts of war, terrorism, and natural disasters; and other factors.
For a more detailed discussion of the more significant of these factors, see “Risk Factors” and “Management’s Discussion and Analysis of Results of Operations and Financial Condition” in our 2019 Form 10-K, filed with the
The forward-looking statements included in this document are made only as of the date of this document, and we undertake no obligation to update these statements to reflect subsequent events or circumstances, other than as may be required by law.
For more information and to listen to a live broadcast or an audio replay of the quarterly conference call with analysts, visit the
Fourth Quarter Financial Summary - Preliminary, unaudited | ||||||||||||||||||||
(In millions, except % and per share amounts) | ||||||||||||||||||||
(14 weeks) | (13 weeks) | |||||||||||||||||||
4Q | 4Q | % Sales Change vs. P/Y | ||||||||||||||||||
2020 |
2019 |
Reported | Ex. Currency | Organic | ||||||||||||||||
(a) | (b) | |||||||||||||||||||
Net sales, by segment: | ||||||||||||||||||||
Label and Graphic Materials |
|
|
10.1% |
3.6% |
3.6% |
|||||||||||||||
Retail Branding and Information Solutions |
508.0 |
426.9 |
19.0% |
11.6% |
3.1% |
|||||||||||||||
Industrial and Healthcare Materials |
188.2 |
169.8 |
10.8% |
0.7% |
0.7% |
|||||||||||||||
Total net sales |
|
|
12.3% |
5.2% |
3.2% |
|||||||||||||||
As Reported (GAAP) | Adjusted Non-GAAP (c) | |||||||||||||||||||
(14 weeks) | (13 weeks) | (14 weeks) | (13 weeks) | |||||||||||||||||
4Q | 4Q | % | % of Sales | 4Q | 4Q | % | % of Sales | |||||||||||||
2020 |
2019 |
Change |
2020 |
2019 |
2020 |
2019 |
Change |
2020 |
2019 |
|||||||||||
Operating income (loss) / operating margins before interest, other non-operating expense (income), and taxes, by segment: | ||||||||||||||||||||
Label and Graphic Materials |
|
|
15.9% |
12.0% |
|
|
15.4% |
13.3% |
||||||||||||
Retail Branding and Information Solutions |
77.5 |
49.1 |
15.3% |
11.5% |
79.6 |
58.1 |
15.7% |
13.6% |
||||||||||||
Industrial and Healthcare Materials |
23.3 |
12.2 |
12.4% |
7.2% |
23.1 |
17.4 |
12.3% |
10.2% |
||||||||||||
Corporate expense |
(33.5) |
(22.1) |
(33.0) |
(19.9) |
||||||||||||||||
Total operating income / operating margins before interest, other non-operating expense (income), and taxes |
|
|
52% |
13.7% |
10.2% |
|
|
27% |
13.5% |
11.9% |
||||||||||
Interest expense |
|
|
|
|
||||||||||||||||
Other non-operating expense (income), net (d) |
|
( |
|
( |
||||||||||||||||
Income before taxes |
|
|
54% |
12.8% |
9.3% |
|
|
30% |
12.7% |
10.9% |
||||||||||
Provision for (benefit from) income taxes |
|
|
|
|
||||||||||||||||
Equity method investment (losses) gains |
( |
( |
( |
( |
||||||||||||||||
Net income |
|
|
18% |
9.6% |
9.2% |
|
|
30% |
9.6% |
8.3% |
||||||||||
Net income per common share, assuming dilution |
|
|
19% |
|
|
31% |
||||||||||||||
Free Cash Flow (e) |
|
|
See accompanying schedules A-4 to A-9 for reconciliations from GAAP to non-GAAP financial measures. | |||||||||||||
(a) |
Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, an extra week in our fiscal year, currency adjustment for transitional reporting of highly inflationary economies and the reclassification of sales between segments. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. | ||||||||||||
(b) |
Organic sales change refers to sales change ex. currency, excluding the estimated impact of product line exits, acquisitions and divestitures. | ||||||||||||
(c) |
Excludes impact of restructuring charges and other items. Corporate expense excludes impact of severance and related costs of |
||||||||||||
(d) |
As reported "Other non-operating expense (income), net" includes pension plan settlements and related charges, net of credits of |
||||||||||||
(e) |
Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for, where applicable, the cash contributions related to the termination of our |
Full Year Financial Summary - Preliminary, unaudited | |||||||||||||||||||||
(in millions, except % and per share amounts) | |||||||||||||||||||||
(53 weeks) | (52 weeks) | % Sales Change vs. P/Y | |||||||||||||||||||
2020 |
2019 |
Reported | Ex. Currency | Organic | |||||||||||||||||
(a) | (b) | ||||||||||||||||||||
Net sales, by segment: | |||||||||||||||||||||
Label and Graphic Materials |
|
|
(0.6%) |
(0.5%) |
(0.5%) |
||||||||||||||||
Retail Branding and Information Solutions |
1,630.9 |
1,650.3 |
(1.2%) |
(2.3%) |
(9.5%) |
||||||||||||||||
Industrial and Healthcare Materials |
625.5 |
673.9 |
(7.2%) |
(8.7%) |
(8.7%) |
||||||||||||||||
Total net sales |
|
|
(1.4%) |
(1.7%) |
(3.4%) |
||||||||||||||||
As Reported (GAAP) | Adjusted Non-GAAP (c) | ||||||||||||||||||||
(53 weeks) | (52 weeks) | % | % of Sales | (53 weeks) | (52 weeks) | % | % of Sales | ||||||||||||||
2020 |
2019 |
Change |
2020 |
2019 |
2020 |
2019 |
Change |
2020 |
2019 |
||||||||||||
Operating income (loss) / operating margins before interest, other non-operating expense (income), and taxes, by segment: | |||||||||||||||||||||
Label and Graphic Materials |
|
|
14.6% |
12.7% |
|
|
15.1% |
13.3% |
|||||||||||||
Retail Branding and Information Solutions |
144.7 |
196.6 |
8.9% |
11.9% |
167.4 |
206.5 |
10.3% |
12.5% |
|||||||||||||
Industrial and Healthcare Materials |
58.2 |
60.0 |
9.3% |
8.9% |
66.6 |
69.4 |
10.6% |
10.3% |
|||||||||||||
Corporate expense |
(82.5) |
(87.6) |
(82.2) |
(82.0) |
|||||||||||||||||
Total operating income / operating margins before interest, other non-operating expense (income), and taxes |
|
|
5% |
11.6% |
10.9% |
|
|
5% |
12.4% |
11.7% |
|||||||||||
Interest expense |
|
|
|
|
|||||||||||||||||
Other non-operating expense (income), net (d) |
|
|
|
|
|||||||||||||||||
Income before taxes |
|
|
196% |
10.6% |
3.5% |
|
|
6% |
11.4% |
10.6% |
|||||||||||
Provision for (benefit from) income taxes (e) |
|
( |
|
|
|||||||||||||||||
Equity method investment (losses) gains |
( |
( |
( |
( |
|||||||||||||||||
Net income |
|
|
83% |
8.0% |
4.3% |
|
|
6% |
8.6% |
7.9% |
|||||||||||
Net income per common share, assuming dilution |
|
|
85% |
|
|
8% |
|||||||||||||||
Free Cash Flow (f) |
|
|
See accompanying schedules A-4 to A-9 for reconciliations from GAAP to non-GAAP financial measures. | |||||||||||||
(a) |
Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, an extra week in our fiscal year, currency adjustment for transitional reporting of highly inflationary economies and the reclassification of sales between segments. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. | ||||||||||||
(b) |
Organic sales change refers to sales change ex. currency, excluding the estimated impact of product line exits, acquisitions and divestitures. | ||||||||||||
(c) |
Excludes impact of restructuring charges and other items. Corporate expense excludes impact of severance and related costs and legal settlement of |
||||||||||||
(d) |
As reported "Other non-operating expense (income), net" includes pension plan settlements and related charges, net of credits of |
||||||||||||
(e) |
As reported "Provision for (benefit from) income taxes" for 2019 includes then-estimated tax benefit of |
||||||||||||
(f) |
Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for, where applicable, the cash contributions related to the termination of our |
A-1 |
||||||||||||
PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||
(In millions, except per share amounts) | ||||||||||||
(UNAUDITED) | ||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||
(14 weeks) | (13 weeks) | (53 weeks) | (52 weeks) | |||||||||
Net sales | $ |
1,990.9 |
$ |
1,772.9 |
$ |
6,971.5 |
$ |
7,070.1 |
||||
Cost of products sold |
1,419.8 |
1,288.2 |
5,048.2 |
5,166.0 |
||||||||
Gross profit |
571.1 |
484.7 |
1,923.3 |
1,904.1 |
||||||||
Marketing, general and administrative expense |
301.8 |
273.1 |
1,060.5 |
1,080.4 |
||||||||
Other expense (income), net(1) |
(3.7) |
31.5 |
53.6 |
53.2 |
||||||||
Interest expense |
15.6 |
17.8 |
70.0 |
75.8 |
||||||||
Other non-operating expense (income), net(2) |
2.1 |
(3.0) |
1.9 |
445.2 |
||||||||
Income before taxes |
255.3 |
165.3 |
737.3 |
249.5 |
||||||||
Provision for (benefit from) income taxes(3) |
62.9 |
2.2 |
177.7 |
(56.7) |
||||||||
Equity method investment (losses) gains |
(0.9) |
(0.6) |
(3.7) |
(2.6) |
||||||||
Net income | $ |
191.5 |
$ |
162.5 |
$ |
555.9 |
$ |
303.6 |
||||
Per share amounts: | ||||||||||||
Net income per common share, assuming dilution | $ |
2.28 |
$ |
1.92 |
$ |
6.61 |
$ |
3.57 |
||||
Weighted average number of common shares outstanding, assuming dilution |
84.1 |
84.5 |
84.1 |
85.0 |
(1) |
"Other expense (income), net" for the fourth quarter of 2020 includes gain on investment of |
|||||||||
|
"Other expense (income), net" for the fourth quarter of 2019 includes severance and related costs of |
|||||||||
|
"Other expense (income), net" for fiscal year 2020 includes severance and related costs of |
|||||||||
|
"Other expense (income), net" for fiscal year 2019 includes severance and related costs of |
|||||||||
(2) |
"Other non-operating expense (income), net" includes pension plan settlements and related charges, net of credits of |
|||||||||
(3) |
"Provision for (benefit from) income taxes" for fiscal year 2019 includes then-estimated tax benefit of |
A-2 |
|||||||
PRELIMINARY CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
(In millions) | |||||||
(UNAUDITED) | |||||||
ASSETS |
|
||||||
Current assets: | |||||||
Cash and cash equivalents | $ |
252.3 |
$ |
253.7 |
|||
Trade accounts receivable, net |
1,235.2 |
1,212.2 |
|||||
Inventories, net |
717.2 |
663.0 |
|||||
Other current assets |
211.5 |
211.7 |
|||||
Total current assets |
2,416.2 |
2,340.6 |
|||||
Property, plant and equipment, net |
1,343.7 |
1,210.7 |
|||||
1,361.3 |
1,057.3 |
||||||
Deferred tax assets |
212.7 |
225.4 |
|||||
Other assets |
765.0 |
654.8 |
|||||
$ |
6,098.9 |
$ |
5,488.8 |
||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Short-term borrowings and current portion of long-term debt and finance leases | $ |
64.7 |
$ |
440.2 |
|||
Accounts payable |
1,050.9 |
1,066.1 |
|||||
Other current liabilities |
810.4 |
747.5 |
|||||
Total current liabilities |
1,926.0 |
2,253.8 |
|||||
Long-term debt and finance leases |
2,052.1 |
1,499.3 |
|||||
Other long-term liabilities |
620.9 |
531.7 |
|||||
Shareholders' equity: | |||||||
Common stock |
124.1 |
124.1 |
|||||
Capital in excess of par value |
862.1 |
874.0 |
|||||
Retained earnings |
3,349.3 |
2,979.1 |
|||||
(2,501.0) |
(2,425.1) |
||||||
Accumulated other comprehensive loss |
(334.6) |
(348.1) |
|||||
Total shareholders' equity |
1,499.9 |
1,204.0 |
|||||
$ |
6,098.9 |
$ |
5,488.8 |
A-3 |
||||||||||
PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||
(In millions) | ||||||||||
(UNAUDITED) | ||||||||||
Twelve Months Ended | ||||||||||
(53 weeks) | (52 weeks) | |||||||||
Operating Activities: | ||||||||||
Net income | $ |
555.9 |
|
$ |
303.6 |
|
||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation |
154.2 |
|
140.3 |
|
||||||
Amortization |
51.1 |
|
38.7 |
|
||||||
Provision for credit losses and sales returns |
64.0 |
|
58.7 |
|
||||||
Stock-based compensation |
24.0 |
|
34.5 |
|
||||||
Pension plan settlements and related charges |
0.5 |
|
444.1 |
|
||||||
Deferred taxes and other non-cash taxes |
9.3 |
|
(216.9 |
) |
||||||
Other non-cash expense and loss (income and gain), net |
44.9 |
|
28.3 |
|
||||||
Changes in assets and liabilities and other adjustments |
(152.6 |
) |
(84.8 |
) |
||||||
Net cash provided by operating activities |
751.3 |
|
746.5 |
|
||||||
Investing Activities: | ||||||||||
Purchases of property, plant and equipment |
(201.4 |
) |
(219.4 |
) |
||||||
Purchases of software and other deferred charges |
(17.2 |
) |
(37.8 |
) |
||||||
Proceeds from sales of property, plant and equipment |
9.2 |
|
7.8 |
|
||||||
Proceeds from insurance and sales (purchases) of investments, net |
5.6 |
|
4.9 |
|
||||||
Payments for acquisitions, net of cash acquired, and investments in businesses |
(350.4 |
) |
(6.5 |
) |
||||||
Net cash used in investing activities |
(554.2 |
) |
(251.0 |
) |
||||||
Financing Activities: | ||||||||||
Net increase (decrease) in borrowings (maturities of three months or less) |
(110.4 |
) |
(5.3 |
) |
||||||
Additional borrowings under revolving credit facility |
500.0 |
|
--- |
|
||||||
Repayments of revolving credit facility |
(500.0 |
) |
--- |
|
||||||
Additional long-term borrowings |
493.7 |
|
--- |
|
||||||
Repayments of long-term debt and finance leases |
(270.2 |
) |
(18.6 |
) |
||||||
Dividends paid |
(196.8 |
) |
(189.7 |
) |
||||||
Share repurchases |
(104.3 |
) |
(237.7 |
) |
||||||
Net (tax withholding) proceeds related to stock-based compensation |
(19.7 |
) |
(17.4 |
) |
||||||
Payments of contingent consideration |
--- |
|
(1.6 |
) |
||||||
Net cash used in financing activities |
(207.7 |
) |
(470.3 |
) |
||||||
Effect of foreign currency translation on cash balances |
9.2 |
|
(3.5 |
) |
||||||
Increase (decrease) in cash and cash equivalents |
(1.4 |
) |
21.7 |
|
||||||
Cash and cash equivalents, beginning of year |
253.7 |
|
232.0 |
|
||||||
Cash and cash equivalents, end of year | $ |
252.3 |
|
$ |
253.7 |
|
A-4 |
Reconciliation of Non-GAAP Financial Measures to GAAP |
We report our financial results in conformity with accounting principles generally accepted in |
|
Our non-GAAP financial measures exclude the impact of certain events, activities or decisions. The accounting effects of these events, activities or decisions, which are included in the GAAP financial measures, may make it difficult to assess our underlying performance in a single period. By excluding the accounting effects, positive or negative, of certain items (e.g., restructuring charges, legal settlements, certain effects of strategic transactions and related costs, losses from debt extinguishments, gains or losses from curtailment or settlement of pension obligations, gains or losses on sales of certain assets, gains or losses on investments, and other items), we believe that we are providing meaningful supplemental information that facilitates an understanding of our core operating results and liquidity measures. While some of the items we exclude from GAAP financial measures recur, they tend to be disparate in amount, frequency, or timing. |
|
We use these non-GAAP financial measures internally to evaluate trends in our underlying performance, as well as to facilitate comparison to the results of competitors for a single period and full year. |
|
We use the following non-GAAP financial measures in the accompanying news release and presentation: |
|
Sales change ex. currency refers to the increase or decrease in net sales, excluding the estimated impact of foreign currency translation, and, where applicable, an extra week in our fiscal year, currency adjustment for transitional reporting of highly inflationary economies, and the reclassification of sales between segments. The estimated impact of foreign currency translation is calculated on a constant currency basis, with prior period results translated at current period average exchange rates to exclude the effect of currency fluctuations. |
|
Organic sales change refers to sales change ex. currency, excluding the estimated impact of product line exits, acquisitions and divestitures. |
|
We believe that sales change ex. currency and organic sales change assist investors in evaluating the sales change from the ongoing activities of our businesses and enhance their ability to evaluate our results from period to period. |
|
Adjusted operating income refers to income before taxes; interest expense; other non-operating expense (income), net; and other expense (income), net. |
|
Adjusted EBITDA refers to adjusted operating income before depreciation and amortization. |
|
Adjusted operating margin refers to adjusted operating income as a percentage of net sales. |
|
Adjusted EBITDA margin refers to adjusted EBITDA as a percentage of net sales. |
|
Adjusted tax rate refers to the full-year GAAP tax rate, adjusted to exclude certain unusual or infrequent events that are expected to significantly impact that rate, such as our |
|
Adjusted net income refers to income before taxes, tax-effected at the adjusted tax rate, and adjusted for tax-effected restructuring charges and other items. |
|
Adjusted net income per common share, assuming dilution (adjusted EPS) refers to adjusted net income divided by weighted average number of common shares outstanding, assuming dilution. |
|
We believe that adjusted operating margin, adjusted EBITDA margin, adjusted net income, and adjusted EPS assist investors in understanding our core operating trends and comparing our results with those of our competitors. |
|
Net debt to adjusted EBITDA ratio refers to total debt (including finance leases) less cash and cash equivalents, divided by adjusted EBITDA for the last twelve months. |
|
We believe that the net debt to adjusted EBITDA ratio assists investors in assessing our leverage position. |
|
Free cash flow refers to cash flow provided by operating activities, less payments for property, plant and equipment, software and other deferred charges, plus proceeds from sales of property, plant and equipment, plus (minus) net proceeds from insurance and sales (purchases) of investments. Free cash flow is also adjusted for, where applicable, the cash contributions related to the termination of our |
|
The following reconciliations are provided in accordance with Regulations G and S-K and reconcile our non-GAAP financial measures with the most directly comparable GAAP financial measures. |
A-5 |
||||||||||||
PRELIMINARY RECONCILIATION FROM GAAP TO NON-GAAP FINANCIAL MEASURES | ||||||||||||
(In millions, except % and per share amounts) | ||||||||||||
|
|
|
|
|||||||||
|
(UNAUDITED) | |||||||||||
|
|
|
|
|||||||||
|
Three Months Ended |
|
Twelve Months Ended | |||||||||
|
|
|
|
|||||||||
|
|
|
|
|||||||||
|
(14 weeks) |
|
(13 weeks) |
|
(53 weeks) |
|
(52 weeks) | |||||
|
|
|
|
|||||||||
Reconciliation from GAAP to Non-GAAP operating margins: |
|
|
|
|
||||||||
Net sales |
$ |
1,990.9 |
$ |
1,772.9 |
$ |
6,971.5 |
$ |
7,070.1 |
||||
Income before taxes |
$ |
255.3 |
$ |
165.3 |
$ |
737.3 |
$ |
249.5 |
||||
Income before taxes as a percentage of net sales |
|
12.8% |
|
9.3% |
|
10.6% |
|
3.5% |
||||
Adjustments: |
|
|
|
|
||||||||
Interest expense |
$ |
15.6 |
$ |
17.8 |
$ |
70.0 |
$ |
75.8 |
||||
Other non-operating expense (income), net |
|
2.1 |
|
(3.0) |
|
1.9 |
|
445.2 |
||||
Operating income before interest expense, other non-operating expense (income), and taxes |
$ |
273.0 |
$ |
180.1 |
$ |
809.2 |
$ |
770.5 |
||||
Operating margins |
|
13.7% |
|
10.2% |
|
11.6% |
|
10.9% |
||||
|
|
|
|
|||||||||
|
|
|
|
|||||||||
Income before taxes |
$ |
255.3 |
$ |
165.3 |
$ |
737.3 |
$ |
249.5 |
||||
Adjustments: |
|
|
|
|
||||||||
Restructuring charges: |
|
|
|
|
||||||||
Severance and related costs |
|
2.7 |
|
25.5 |
|
49.1 |
|
45.3 |
||||
Asset impairment and lease cancellation charges |
|
--- |
|
3.4 |
|
6.2 |
|
5.1 |
||||
Net gain on investments |
|
(6.9) |
|
--- |
|
(5.4) |
|
--- |
||||
Transaction and related costs |
|
1.0 |
|
2.6 |
|
4.2 |
|
2.6 |
||||
Legal settlement |
|
--- |
|
--- |
|
--- |
|
3.4 |
||||
Gain on sales of assets |
|
(0.5) |
|
--- |
|
(0.5) |
|
(3.2) |
||||
Interest expense |
|
15.6 |
|
17.8 |
|
70.0 |
|
75.8 |
||||
Other non-operating expense (income), net |
|
2.1 |
|
(3.0) |
|
1.9 |
|
445.2 |
||||
Adjusted operating income (non-GAAP) |
$ |
269.3 |
$ |
211.6 |
$ |
862.8 |
$ |
823.7 |
||||
Adjusted operating margins (non-GAAP) |
|
13.5% |
|
11.9% |
|
12.4% |
|
11.7% |
||||
|
|
|
|
|||||||||
Reconciliation from GAAP to Non-GAAP net income: |
|
|
|
|
||||||||
As reported net income |
$ |
191.5 |
$ |
162.5 |
$ |
555.9 |
$ |
303.6 |
||||
Adjustments: |
|
|
|
|
||||||||
Restructuring charges and other items(1) |
|
(3.7) |
|
31.5 |
|
53.6 |
|
53.2 |
||||
Pension plan settlements and related charges |
|
0.5 |
|
(2.8) |
|
0.5 |
|
444.1 |
||||
Tax benefit from pension plan settlements and related charges |
|
--- |
|
0.8 |
|
--- |
|
(179.0) |
||||
Tax benefit from discrete foreign tax structuring and planning transactions |
|
--- |
|
(47.9) |
|
--- |
|
(47.9) |
||||
Tax effect on restructuring charges and other items and impact of adjusted tax rate |
|
2.2 |
|
2.4 |
|
(13.0) |
|
(13.2) |
||||
Adjusted net income (non-GAAP) |
$ |
190.5 |
$ |
146.5 |
$ |
597.0 |
$ |
560.8 |
(1) |
Includes pretax restructuring and related charges, transaction and related costs, legal settlement, net gain on investments, and gain on sales of assets. |
A-5
|
||||||||||||
PRELIMINARY RECONCILIATION FROM GAAP TO NON-GAAP FINANCIAL MEASURES | ||||||||||||
(In millions, except % and per share amounts) | ||||||||||||
(UNAUDITED) | ||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||
(14 weeks) | (13 weeks) | (53 weeks) | (52 weeks) | |||||||||
Reconciliation from GAAP to Non-GAAP net income per common share: | ||||||||||||
As reported net income per common share, assuming dilution | $ |
2.28 |
$ |
1.92 |
$ |
6.61 |
$ |
3.57 |
||||
Adjustments per common share, net of tax: | ||||||||||||
Restructuring charges and other items(1) |
(0.05) |
0.37 |
0.64 |
0.63 |
||||||||
Pension plan settlements and related charges |
0.01 |
(0.02) |
0.01 |
3.12 |
||||||||
Tax benefit from discrete foreign tax structuring and planning transactions |
--- |
(0.57) |
--- |
(0.56) |
||||||||
Tax effect on restructuring charges and other items and impact of adjusted tax rate |
0.03 |
0.03 |
(0.16) |
(0.16) |
||||||||
Adjusted net income per common share, assuming dilution (non-GAAP) | $ |
2.27 |
$ |
1.73 |
$ |
7.10 |
$ |
6.60 |
||||
Weighted average number of common shares outstanding, assuming dilution |
84.1 |
84.5 |
84.1 |
85.0 |
||||||||
Our adjusted tax rate was 24.1% for the three and twelve months ended |
||||||||||||
(1) Includes pretax restructuring and related charges, transaction and related costs, legal settlement, net gain on investments, and gain on sales of assets. | ||||||||||||
(UNAUDITED) | ||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||
(14 weeks) | (13 weeks) | (53 weeks) | (52 weeks) | |||||||||
Reconciliation of free cash flow: | ||||||||||||
Net cash provided by operating activities | $ |
309.5 |
$ |
279.5 |
$ |
751.3 |
$ |
746.5 |
||||
Purchases of property, plant and equipment |
(109.7) |
(86.5) |
(201.4) |
(219.4) |
||||||||
Purchases of software and other deferred charges |
(3.4) |
(10.4) |
(17.2) |
(37.8) |
||||||||
Proceeds from sales of property, plant and equipment |
9.0 |
0.1 |
9.2 |
7.8 |
||||||||
Proceeds from insurance and sales (purchases) of investments, net |
0.4 |
1.4 |
5.6 |
4.9 |
||||||||
Contributions for |
--- |
0.8 |
--- |
10.3 |
||||||||
Free cash flow (non-GAAP) | $ |
205.8 |
$ |
184.9 |
$ |
547.5 |
$ |
512.3 |
A-6 |
||||||||||||||||||||
PRELIMINARY SUPPLEMENTARY INFORMATION | ||||||||||||||||||||
(In millions, except %) | ||||||||||||||||||||
(UNAUDITED) | ||||||||||||||||||||
Fourth Quarter Ended | ||||||||||||||||||||
OPERATING INCOME (LOSS) | OPERATING MARGINS | |||||||||||||||||||
2020 |
|
2019 |
|
2020 |
|
2019 |
|
2020 |
|
2019 |
||||||||||
(14 weeks) | (13 weeks) | (14 weeks) | (13 weeks) | (14 weeks) | (13 weeks) | |||||||||||||||
Label and Graphic Materials |
$ |
1,294.7 |
$ |
1,176.2 |
$ |
205.7 |
|
$ |
140.9 |
|
15.9 |
% |
12.0 |
% |
||||||
Retail Branding and Information Solutions |
|
508.0 |
|
426.9 |
|
77.5 |
|
|
49.1 |
|
15.3 |
% |
11.5 |
% |
||||||
Industrial and Healthcare Materials |
|
188.2 |
|
169.8 |
|
23.3 |
|
|
12.2 |
|
12.4 |
% |
7.2 |
% |
||||||
Corporate Expense |
|
N/A |
|
N/A |
|
(33.5 |
) |
|
(22.1 |
) |
N/A |
|
N/A |
|
||||||
TOTAL FROM OPERATIONS |
$ |
1,990.9 |
$ |
1,772.9 |
$ |
273.0 |
|
$ |
180.1 |
|
13.7 |
% |
10.2 |
% |
||||||
RECONCILIATION FROM GAAP TO NON-GAAP SUPPLEMENTARY INFORMATION | ||||||||||||||||||||
Fourth Quarter Ended | ||||||||||||||||||||
OPERATING INCOME | OPERATING MARGINS | |||||||||||||||||||
|
2020 |
|
|
2019 |
|
2020 |
|
2019 |
|
|||||||||||
Label and Graphic Materials | ||||||||||||||||||||
Operating income and margins, as reported |
$ |
205.7 |
|
$ |
140.9 |
|
15.9 |
% |
12.0 |
% |
||||||||||
Adjustments: | ||||||||||||||||||||
Restructuring charges: |
||||||||||||||||||||
Severance and related costs |
|
0.3 |
|
|
15.1 |
|
--- |
|
1.3 |
% |
||||||||||
Transaction costs |
|
1.0 |
|
|
--- |
|
0.1 |
% |
--- |
|
||||||||||
Gain on investment |
|
(6.9 |
) |
|
--- |
|
(0.5 |
%) |
--- |
|
||||||||||
Gain on sale of assets |
|
(0.5 |
) |
|
--- |
|
(0.1 |
%) |
--- |
|
||||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
199.6 |
|
$ |
156.0 |
|
15.4 |
% |
13.3 |
% |
||||||||||
Retail Branding and Information Solutions | ||||||||||||||||||||
Operating income and margins, as reported |
$ |
77.5 |
|
$ |
49.1 |
|
15.3 |
% |
11.5 |
% |
||||||||||
Adjustments: | ||||||||||||||||||||
Restructuring charges: | ||||||||||||||||||||
Severance and related costs |
|
2.1 |
|
|
6.3 |
|
0.4 |
% |
1.5 |
% |
||||||||||
Asset impairment charges |
|
--- |
|
|
0.1 |
|
--- |
|
--- |
|
||||||||||
Transaction costs |
|
--- |
|
|
2.6 |
|
--- |
|
0.6 |
% |
||||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
79.6 |
|
$ |
58.1 |
|
15.7 |
% |
13.6 |
% |
||||||||||
Industrial and Healthcare Materials | ||||||||||||||||||||
Operating income and margins, as reported |
$ |
23.3 |
|
$ |
12.2 |
|
12.4 |
% |
7.2 |
% |
||||||||||
Adjustments: | ||||||||||||||||||||
Restructuring charges: | ||||||||||||||||||||
Severance and related costs |
|
(0.2 |
) |
|
1.9 |
|
(0.1 |
%) |
1.1 |
% |
||||||||||
Asset impairment charges |
|
--- |
|
|
3.3 |
|
--- |
|
1.9 |
% |
||||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
23.1 |
|
$ |
17.4 |
|
12.3 |
% |
10.2 |
% |
A-7 |
||||||||||||||||||
PRELIMINARY SUPPLEMENTARY INFORMATION | ||||||||||||||||||
(In millions, except %) | ||||||||||||||||||
(UNAUDITED) | ||||||||||||||||||
Twelve Months Ended | ||||||||||||||||||
OPERATING INCOME (LOSS) | OPERATING MARGINS | |||||||||||||||||
2020 |
|
2019 |
|
2020 |
2019 |
|
2020 |
2019 |
||||||||||
(53 weeks) | (52 weeks) | (53 weeks) | (52 weeks) | (53 weeks) | (52 weeks) | |||||||||||||
Label and Graphic Materials |
$ |
4,715.1 |
$ |
4,745.9 |
$ |
688.8 |
|
$ |
601.5 |
|
14.6 |
% |
12.7 |
% |
||||
Retail Branding and Information Solutions |
|
1,630.9 |
|
1,650.3 |
|
144.7 |
|
|
196.6 |
|
8.9 |
% |
11.9 |
% |
||||
Industrial and Healthcare Materials |
|
625.5 |
|
673.9 |
|
58.2 |
|
|
60.0 |
|
9.3 |
% |
8.9 |
% |
||||
Corporate Expense |
|
N/A |
|
N/A |
|
(82.5 |
) |
|
(87.6 |
) |
N/A |
|
N/A |
|
||||
TOTAL FROM OPERATIONS |
$ |
6,971.5 |
$ |
7,070.1 |
$ |
809.2 |
|
$ |
770.5 |
|
11.6 |
% |
10.9 |
% |
||||
RECONCILIATION FROM GAAP TO NON-GAAP SUPPLEMENTARY INFORMATION | ||||||||||||||||||
Twelve Months Ended | ||||||||||||||||||
OPERATING INCOME | OPERATING MARGINS | |||||||||||||||||
|
2020 |
|
|
2019 |
|
2020 |
|
2019 |
|
|||||||||
Label and Graphic Materials | ||||||||||||||||||
Operating income and margins, as reported |
$ |
688.8 |
|
$ |
601.5 |
|
14.6 |
% |
12.7 |
% |
||||||||
Adjustments: | ||||||||||||||||||
Restructuring charges: | ||||||||||||||||||
Severance and related costs |
|
27.0 |
|
|
27.7 |
|
0.6 |
% |
0.6 |
% |
||||||||
Asset impairment and lease cancellation charges |
|
0.9 |
|
|
1.3 |
|
--- |
|
--- |
|
||||||||
Transaction and related costs |
|
1.7 |
|
|
--- |
|
--- |
|
--- |
|
||||||||
Gain on investment |
|
(6.9 |
) |
|
--- |
|
(0.1 |
%) |
--- |
|
||||||||
Gain on sales of assets |
|
(0.5 |
) |
|
(0.7 |
) |
--- |
|
--- |
|
||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
711.0 |
|
$ |
629.8 |
|
15.1 |
% |
13.3 |
% |
||||||||
Depreciation and amortization |
|
107.0 |
|
|
99.9 |
|
2.2 |
% |
2.1 |
% |
||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ |
818.0 |
|
$ |
729.7 |
|
17.3 |
% |
15.4 |
% |
||||||||
Retail Branding and Information Solutions | ||||||||||||||||||
Operating income and margins, as reported |
$ |
144.7 |
|
$ |
196.6 |
|
8.9 |
% |
11.9 |
% |
||||||||
Adjustments: | ||||||||||||||||||
Restructuring charges: | ||||||||||||||||||
Severance and related costs |
|
17.1 |
|
|
9.3 |
|
1.0 |
% |
0.6 |
% |
||||||||
Asset impairment charges |
|
1.6 |
|
|
0.5 |
|
0.1 |
% |
--- |
|
||||||||
Transaction and related costs |
|
2.5 |
|
|
2.6 |
|
0.2 |
% |
0.2 |
% |
||||||||
Loss on investment |
|
1.5 |
|
|
--- |
|
0.1 |
% |
--- |
|
||||||||
Gain on sale of assets |
|
--- |
|
|
(2.5 |
) |
--- |
|
(0.2 |
%) |
||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
167.4 |
|
$ |
206.5 |
|
10.3 |
% |
12.5 |
% |
||||||||
Depreciation and amortization |
|
71.6 |
|
|
52.9 |
|
4.4 |
% |
3.2 |
% |
||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ |
239.0 |
|
$ |
259.4 |
|
14.7 |
% |
15.7 |
% |
||||||||
Industrial and Healthcare Materials | ||||||||||||||||||
Operating income and margins, as reported |
$ |
58.2 |
|
$ |
60.0 |
|
9.3 |
% |
8.9 |
% |
||||||||
Adjustments: | ||||||||||||||||||
Restructuring charges: | ||||||||||||||||||
Severance and related costs |
|
4.7 |
|
|
6.1 |
|
0.7 |
% |
0.9 |
% |
||||||||
Asset impairment charges |
|
3.7 |
|
|
3.3 |
|
0.6 |
% |
0.5 |
% |
||||||||
Adjusted operating income and margins (non-GAAP) |
$ |
66.6 |
|
$ |
69.4 |
|
10.6 |
% |
10.3 |
% |
||||||||
Depreciation and amortization |
|
26.7 |
|
|
26.2 |
|
4.3 |
% |
3.9 |
% |
||||||||
Adjusted EBITDA and margins (non-GAAP) |
$ |
93.3 |
|
$ |
95.6 |
|
14.9 |
% |
14.2 |
% |
A-8 |
|||||||||||||||||||||||||||||
PRELIMINARY SUPPLEMENTARY INFORMATION | |||||||||||||||||||||||||||||
($ in millions) | |||||||||||||||||||||||||||||
(UNAUDITED) | |||||||||||||||||||||||||||||
Reconciliation of Adjusted EBITDA Margins and Net Debt to Adjusted EBITDA | |||||||||||||||||||||||||||||
QTD | YTD | QTD | YTD | ||||||||||||||||||||||||||
Total Company |
|
1Q19 |
|
|
2Q19 |
|
|
3Q19 |
|
|
4Q19 |
|
|
2019 |
|
|
1Q20 |
|
|
2Q20 |
|
|
3Q20 |
|
|
4Q20 |
|
|
2020 |
Net sales |
$ |
1,740.1 |
$ |
1,795.7 |
$ |
1,761.4 |
$ |
1,772.9 |
$ |
7,070.1 |
$ |
1,723.0 |
$ |
1,528.5 |
$ |
1,729.1 |
$ |
1,990.9 |
$ |
6,971.5 |
|||||||||
Operating income before interest expense, other non-operating expense (income), and taxes, as reported |
|
181.6 |
|
209.1 |
|
199.7 |
|
180.1 |
|
770.5 |
|
199.2 |
|
123.5 |
|
213.5 |
|
273.0 |
|
809.2 |
|||||||||
Operating margins, as reported |
|
10.4% |
|
11.6% |
|
11.3% |
|
10.2% |
|
10.9% |
|
11.6% |
|
8.1% |
|
12.3% |
|
13.7% |
|
11.6% |
|||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||||||||
Restructuring charges: | |||||||||||||||||||||||||||||
Severance and related costs |
|
10.4 |
|
6.1 |
|
3.3 |
|
25.5 |
|
45.3 |
|
2.4 |
|
37.5 |
|
6.5 |
|
2.7 |
|
49.1 |
|||||||||
Asset impairment and lease cancellation charges |
|
0.3 |
|
1.4 |
|
- |
|
3.4 |
|
5.1 |
|
- |
|
1.8 |
|
4.4 |
|
- |
|
6.2 |
|||||||||
Other items |
|
(3.2) |
|
- |
|
3.4 |
|
2.6 |
|
2.8 |
|
2.5 |
|
0.7 |
|
1.5 |
|
(6.4) |
|
(1.7) |
|||||||||
Adjusted operating income (non-GAAP) |
$ |
189.1 |
$ |
216.6 |
$ |
206.4 |
$ |
211.6 |
$ |
823.7 |
$ |
204.1 |
$ |
163.5 |
$ |
225.9 |
$ |
269.3 |
$ |
862.8 |
|||||||||
Adjusted operating margins (non-GAAP) |
|
10.9% |
|
12.1% |
|
11.7% |
|
11.9% |
|
11.7% |
|
11.8% |
|
10.7% |
|
13.1% |
|
13.5% |
|
12.4% |
|||||||||
Depreciation and amortization |
$ |
44.5 |
$ |
44.9 |
$ |
44.0 |
$ |
45.6 |
$ |
179.0 |
$ |
47.5 |
$ |
50.3 |
$ |
52.0 |
$ |
55.5 |
$ |
205.3 |
|||||||||
Adjusted EBITDA (non-GAAP) |
$ |
233.6 |
$ |
261.5 |
$ |
250.4 |
$ |
257.2 |
$ |
1,002.7 |
$ |
251.6 |
$ |
213.8 |
$ |
277.9 |
$ |
324.8 |
$ |
1,068.1 |
|||||||||
Adjusted EBITDA margins (non-GAAP) |
|
13.4% |
|
14.6% |
|
14.2% |
|
14.5% |
|
14.2% |
|
14.6% |
|
14.0% |
|
16.1% |
|
16.3% |
|
15.3% |
|||||||||
Total Debt |
$ |
2,820.3 |
$ |
2,266.2 |
$ |
2,144.1 |
$ |
2,116.8 |
|||||||||||||||||||||
Less: Cash and cash equivalents |
|
742.0 |
|
262.6 |
|
284.7 |
|
252.3 |
|||||||||||||||||||||
Net Debt |
$ |
2,078.3 |
$ |
2,003.6 |
$ |
1,859.4 |
$ |
1,864.5 |
|||||||||||||||||||||
Net Debt to Adjusted EBITDA LTM* (non-GAAP) |
|
1.7 |
|||||||||||||||||||||||||||
*LTM = Last twelve months (1Q20 to 4Q20) |
A-9 |
||||
PRELIMINARY SUPPLEMENTARY INFORMATION | ||||
(UNAUDITED) | ||||
Fourth Quarter 2020 | ||||
Total Company |
Label and
Materials |
Retail Branding and Information Solutions |
Industrial and Healthcare Materials |
|
Reconciliation from GAAP to Non-GAAP sales change | ||||
Reported net sales change |
12.3% |
10.1% |
19.0% |
10.8% |
Foreign currency translation |
(2.3%) |
(2.5%) |
(0.9%) |
(4.0%) |
Extra week impact |
(4.9%) |
(4.1%) |
(6.6%) |
(6.1%) |
Sales change ex. currency (non-GAAP)(1) |
5.2% |
3.6% |
11.6% |
0.7% |
Acquisitions |
(2.0%) |
--- |
(8.4%) |
--- |
Organic sales change (non-GAAP)(1) |
3.2% |
3.6% |
3.1% |
0.7% |
Full Year 2020 | ||||
Total Company |
Label and Graphic Materials |
Retail Branding and Information Solutions |
Industrial and Healthcare Materials |
|
Reconciliation from GAAP to Non-GAAP sales change | ||||
Reported net sales change |
(1.4%) |
(0.6%) |
(1.2%) |
(7.2%) |
Foreign currency translation |
0.9% |
1.2% |
0.6% |
0.1% |
Extra week impact |
(1.3%) |
(1.0%) |
(1.7%) |
(1.6%) |
Sales change ex. currency (non-GAAP)(1) |
(1.7%) |
(0.5%) |
(2.3%) |
(8.7%) |
Acquisitions |
(1.7%) |
--- |
(7.2%) |
--- |
Organic sales change (non-GAAP)(1) |
(3.4%) |
(0.5%) |
(9.5%) |
(8.7%) |
(1) Totals may not sum due to rounding. |
A-9
|
||||||||||||||||||||
PRELIMINARY SUPPLEMENTARY INFORMATION | ||||||||||||||||||||
2020 Monthly Sales Trends (comparisons to prior year) | ||||||||||||||||||||
(UNAUDITED) | ||||||||||||||||||||
Total Company | ||||||||||||||||||||
Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |||||||||||
Reconciliation from GAAP to Non-GAAP sales change | ||||||||||||||||||||
Reported net sales change(1) |
2 |
% |
(18 |
%) |
(15 |
%) |
(12 |
%) |
(7 |
%) |
(1 |
%) |
1 |
% |
7 |
% |
23 |
% |
9 |
% |
Foreign currency translation |
3 |
% |
3 |
% |
3 |
% |
3 |
% |
3 |
% |
1 |
% |
(1 |
%) |
(2 |
%) |
(2 |
%) |
(3 |
%) |
Extra week impact |
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
(16 |
%) |
--- |
|
Sales change ex. currency (non-GAAP)(2) |
5 |
% |
(16 |
%) |
(11 |
%) |
(10 |
%) |
(4 |
%) |
--- |
|
--- |
|
5 |
% |
5 |
% |
6 |
% |
Acquisitions |
(2 |
%) |
(2 |
%) |
(2 |
%) |
(2 |
%) |
(3 |
%) |
(2 |
%) |
(2 |
%) |
(2 |
%) |
(2 |
%) |
(2 |
%) |
Organic sales change (non-GAAP)(2) |
3 |
% |
(17 |
%) |
(13 |
%) |
(11 |
%) |
(7 |
%) |
(2 |
%) |
(2 |
%) |
3 |
% |
3 |
% |
4 |
% |
Label and Graphic Materials | ||||||||||||||||||||
Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |||||||||||
Reconciliation from GAAP to Non-GAAP sales change | ||||||||||||||||||||
Reported net sales change(1) |
1 |
% |
(7 |
%) |
(7 |
%) |
(11 |
%) |
(9 |
%) |
(2 |
%) |
--- |
|
4 |
% |
19 |
% |
9 |
% |
Foreign currency translation |
4 |
% |
4 |
% |
5 |
% |
3 |
% |
3 |
% |
1 |
% |
(1 |
%) |
(2 |
%) |
(2 |
%) |
(3 |
%) |
Extra week impact |
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
(13 |
%) |
--- |
|
Sales change ex. currency (non-GAAP)(2) |
5 |
% |
(4 |
%) |
(2 |
%) |
(8 |
%) |
(6 |
%) |
(1 |
%) |
(1 |
%) |
2 |
% |
3 |
% |
6 |
% |
Acquisitions |
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
Organic sales change (non-GAAP)(2) |
5 |
% |
(4 |
%) |
(2 |
%) |
(8 |
%) |
(6 |
%) |
(1 |
%) |
(1 |
%) |
2 |
% |
3 |
% |
6 |
% |
Retail Branding and Information Solutions | ||||||||||||||||||||
Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |||||||||||
Reconciliation from GAAP to Non-GAAP sales change | ||||||||||||||||||||
Reported net sales change(1) |
8 |
% |
(48 |
%) |
(32 |
%) |
(10 |
%) |
5 |
% |
5 |
% |
4 |
% |
15 |
% |
34 |
% |
12 |
% |
Foreign currency translation |
2 |
% |
1 |
% |
1 |
% |
1 |
% |
2 |
% |
1 |
% |
--- |
|
--- |
|
(1 |
%) |
(1 |
%) |
Extra week impact |
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
(23 |
%) |
--- |
|
Sales change ex. currency (non-GAAP)(2) |
9 |
% |
(47 |
%) |
(30 |
%) |
(9 |
%) |
7 |
% |
6 |
% |
4 |
% |
15 |
% |
10 |
% |
10 |
% |
Acquisitions |
(7 |
%) |
(7 |
%) |
(7 |
%) |
(8 |
%) |
(12 |
%) |
(11 |
%) |
(8 |
%) |
(9 |
%) |
(8 |
%) |
(8 |
%) |
Organic sales change (non-GAAP)(2) |
2 |
% |
(54 |
%) |
(38 |
%) |
(17 |
%) |
(5 |
%) |
(5 |
%) |
(5 |
%) |
6 |
% |
2 |
% |
2 |
% |
Industrial and Healthcare Materials | ||||||||||||||||||||
Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |||||||||||
Reconciliation from GAAP to Non-GAAP sales change | ||||||||||||||||||||
Reported net sales change(1) |
(8 |
%) |
(19 |
%) |
(27 |
%) |
(22 |
%) |
(17 |
%) |
(5 |
%) |
(1 |
%) |
6 |
% |
26 |
% |
2 |
% |
Foreign currency translation |
3 |
% |
2 |
% |
2 |
% |
2 |
% |
2 |
% |
--- |
|
(2 |
%) |
(3 |
%) |
(4 |
%) |
(4 |
%) |
Extra week impact |
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
(20 |
%) |
--- |
|
Sales change ex. currency (non-GAAP)(2) |
(6 |
%) |
(17 |
%) |
(25 |
%) |
(21 |
%) |
(15 |
%) |
(5 |
%) |
(4 |
%) |
3 |
% |
2 |
% |
(3 |
%) |
Acquisitions |
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
--- |
|
Organic sales change (non-GAAP)(2) |
(6 |
%) |
(17 |
%) |
(25 |
%) |
(21 |
%) |
(15 |
%) |
(5 |
%) |
(4 |
%) |
3 |
% |
2 |
% |
(3 |
%) |
(1) Includes an extra week in Nov. | ||||||||||||||||||||
(2) Totals may not sum due to rounding. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210203005247/en/
Media Relations:
rob.six@averydennison.com
Investor Relations:
john.eble@averydennison.com
Source: